TrueWealth LLC’s Novo Nordisk NVO Stock Holding History

TrueWealth LLC’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$285K	Sell	8,704 -140	-2%	-$4.47K	0.12%	104
2020 Q1	$266K	Sell	8,844 -266	-3%	-$7.92K	0.13%	102
2019 Q4	$264K	Sell	9,110 -116	-1%	-$3.21K	0.11%	112
2019 Q3	$238K	Hold	9,226	–	–	0.1%	114
2019 Q2	$235K	Hold	9,226	–	–	0.1%	122
2019 Q1	$241K	Hold	9,226	–	–	0.11%	113
2018 Q4	$213K	Hold	9,226	–	–	0.11%	116
2018 Q3	$217K	Sell	9,226 -716	-7%	-$17.5K	0.1%	122
2018 Q2	$229K	Sell	9,942 -758	-7%	-$18K	0.11%	118
2018 Q1	$263K	Hold	10,700	–	–	0.13%	109
2017 Q4	$287K	Buy	+10,700	New	+$272K	0.13%	103

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

EHC

Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

TrueWealth LLC's NVO Position: Q2 2020 in Review

TrueWealth LLC reduced its Novo Nordisk (NVO) stake by 1.6% in Q2 2020, selling an estimated $4.47K and leaving 8,704 shares worth $285K. The position accounts for 0.12% of the portfolio, ranked #104.

TrueWealth LLC first reported a position in NVO in Q4 2017 and has held it in 11 quarters since. The position peaked at $287K in Q4 2017. 661 funds tracked by Wall St. Rank hold NVO as of Q2 2020.

TrueWealth LLC held 8,704 shares of Novo Nordisk worth $285K as of Q2 2020.
TrueWealth LLC sold 140 Novo Nordisk shares in Q2 2020, an estimated $4.47K.
Novo Nordisk made up 0.12% of TrueWealth LLC's portfolio in Q2 2020, its #104 holding.
TrueWealth LLC first reported a position in Novo Nordisk in Q4 2017 and has held it in 11 quarters since.
TrueWealth LLC's Novo Nordisk position peaked at $287K in Q4 2017.
661 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2020.

Based on TrueWealth LLC's 13F filing for Q2 2020, filed 15 Jul 2020.